Table 1.
Key features of T-2307.
Mechanism of Action | Causes the collapse of the mitochondrial membrane potential by targeting respiratory chain enzymatic complexes III and IV in the inner mitochondrial membrane of yeasts. |
Spectrum of Activity |
Candida species, including azole- and echinocandin-resistant isolates, Cryptococcus neoformans & C. gattii. Variable activity against Aspergillus species. Limited in vitro data against fungi suggests limited to no activity against Fusarium, Scedosporium, and the Mucorales. |
In vivo activity | Efficacy in murine models of invasive candidiasis caused by C. albicans, C. glabrata, and C. auris; reductions in the ocular fungal burden caused by C. albicans. Efficacy in murine models of systemic aspergillosis due to Aspergillus fumigatus and cryptococcosis caused by C. neoformans and C. gattii. |
Pharmacokinetic and clinical data | Not currently available in the literature. |